CompuGroup Medical Reports Decline in Profit and Revenue for First Half of 2023

Financial Performance

CompuGroup Medical SE & Co. KGaA, a prominent player in the healthcare technology sector, has reported a notable decline in its financial performance for the first half of 2023. The company's profit after taxes dropped significantly to €17.3 million, down from €46.1 million in the same period last year 1

1

. This represents a substantial decrease of 62.5% year-over-year.

The company's revenue also experienced a slight contraction, falling by 1% to €532.1 million compared to €536.3 million in the first half of 2022 2

2

. This decline was primarily attributed to the challenging market conditions and the ongoing transformation within the company.

Segment Performance

CompuGroup Medical's performance varied across its different business segments:

1. Ambulatory Information Systems: Revenue increased by 2% to €248.9 million.
2. Hospital Information Systems: Revenue grew by 4% to €131.5 million.
3. Consumer and Health Management Information Systems: Revenue declined by 15% to €112.9 million.
4. Pharmacy Information Systems: Revenue decreased by 3% to €38.8 million 3

   3

   .

Earnings and Profitability

The company's adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) fell by 6% to €105.6 million. This decline was less severe than the drop in net profit, indicating that the company managed to partially mitigate the impact of revenue decline through cost management 1

1

.

Outlook and Management Response

Despite the challenging first half, CompuGroup Medical has maintained its full-year outlook for 2023. The company expects organic growth of approximately 5% and an adjusted EBITDA between €260 million and €300 million 2

2

.

CEO Michael Rauch commented on the results, stating, "We are not satisfied with the business development in the first half of the year." However, he expressed confidence in the company's ability to achieve its full-year targets, citing expected improvements in the second half of 2023 3

3

.

Market Response

Following the announcement of these results, CompuGroup Medical's shares experienced a decline on the Frankfurt Stock Exchange. This reaction reflects investor concerns about the company's performance and its ability to meet full-year targets 1

1

.